Systematic review with meta-analysis: Rifaximin for the prophylaxis of spontaneous bacterial peritonitis
Alimentary Pharmacology and Therapeutics | Oct 13, 2017
Goel A, et al. - The efficacy of rifaximin in the primary and secondary prevention of spontaneous bacterial peritonitis (SBP) was assessed in this meta-analysis. In preventing SBP, rifaximin could be effective in patients with cirrhosis and ascites compared to systemically absorbed antibiotics and compared to placebo.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
